| Cheryl A Meyers, | |
|
1400 Noyes St, Utica, NY 13502-3854 | |
| (315) 797-6800 | |
| Not Available |
| Full Name | Cheryl A Meyers |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 1400 Noyes St, Utica, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114042025 | NPI | - | NPPES |
| 330600 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 330600 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cheryl A Meyers, 10 Sherman Oaks Dr, New Hartford, NY 13413-2040 Ph: () - | Cheryl A Meyers, 1400 Noyes St, Utica, NY 13502-3854 Ph: (315) 797-6800 |
News Archive
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that it has successfully treated Duchenne muscular dystrophy (DMD) in an animal model with its proprietary gene therapy. The proof of concept studies were performed in collaboration with the group of Professor Irene Bozzoni (University of Rome, La Sapienza, Italy) and demonstrated effectiveness in the heart as well as in skeletal muscles.
The University of Toronto's teaching hospitals are all equipped to perform uterine fibroid embolization (UFE), but many women suffering from benign fibroids aren't aware that there's a procedure that can spare their uterus, says Gaylene Pron, professor of public health sciences and author of two 2003 studies evaluating the success of the procedure.
Encision Inc., a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced financial results for its fiscal 2016 first quarter that ended June 30, 2015.
Flamel Technologies today announced the initiation of a Phase 2a clinical trial of Flamel's Interferon alpha-2b XL (IFN-alpha-2b XL), which is based on Flamel's Medusa® platform for controlled release of biologics. IFN-alpha-2b XL is being developed as a controlled release of unmodified interferon alpha-2b for the treatment of chronic hepatitis C virus (HCV).
Web- and telehealth-based delivery of cognitive behavioral therapy is effective for treating chronic insomnia, giving rural-dwelling adults more choice and better access to services, researchers report.
› Verified 6 days ago
Sarah Dunham, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1650 Champlin Ave, Utica, NY 13502 Phone: 315-624-8400 | |
Cynthia A Altieri, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1400 Noyes St, Utica, NY 13502 Phone: 315-797-6800 | |
Thet Thet Mar, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 120 Hobart St, Utica, NY 13501 Phone: 315-798-1149 Fax: 315-734-3565 | |
Barbara Jean Drake, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2211 Genesee St Ste 200, Utica, NY 13501 Phone: 315-733-7598 Fax: 315-733-7694 | |
Michael S Babula, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1001 Noyes St, Utica, NY 13502 Phone: 315-624-9471 Fax: 315-922-9502 | |
Vicki A. Haines, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1656 Champlin Ave, Suite 203, Utica, NY 13502 Phone: 315-738-0647 Fax: 315-738-9719 | |
Mrs. Susan Mary Kolb, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Digestive Disease Medicine Of Cny, Llp, 116 Business Park Drive, 1st Floor, Utica, NY 13502 Phone: 315-624-7000 Fax: 315-793-1129 |